Chinese Journal of Stroke ›› 2024, Vol. 19 ›› Issue (4): 405-413.DOI: 10.3969/j.issn.1673-5765.2024.04.003
Previous Articles Next Articles
HU Kun1, GUAN Ling2,3, WANG Yilong2,3,4,5,6,7,8
Received:
2023-12-13
Online:
2024-04-20
Published:
2024-04-20
Contact:
WANG Yilong, E-mail: yilong528@aliyun. com
胡琨1,管玲2,3,王伊龙2,3,4,5,6,7,8
通讯作者:
王伊龙 yilong528@aliyun.com
基金资助:
CLC Number:
HU Kun, GUAN Ling, WANG Yilong. Research Progress on the Relationship between Various Neuropsychological Symptoms and Imaging of Cerebral Small Vessel Disease[J]. Chinese Journal of Stroke, 2024, 19(4): 405-413.
胡琨, 管玲, 王伊龙. 不同神经心理症状与脑小血管病影像学关系的研究进展[J]. 中国卒中杂志, 2024, 19(4): 405-413.
[1] LI Q,YANG Y,REIS C,et al. Cerebral small vessel disease[J]. Cell Transplant,2018,27(12):1711-1722. [2] BERROCAL-IZQUIERDO N,BIOQUE M,BERNARDO M. Is cerebrovascular disease a silent condition in patients with chronic schizophrenia-related disorders?[J]. Int Clin Psychopharmacol,2017,32(2):80-86. [3] VAN AGTMAAL M J M,HOUBEN A J H M,POUWER F,et al. Association of microvascular dysfunction with late-life depression:a systematic review and meta-analysis[J]. JAMA Psychiatry,2017,74(7):729-739. [4] 叶瑾怡,王赞,龚宇田,等. 脑小血管病研究的神经影像学标准STRIVE-2——自2013年以来的新进展[J]. 中国卒中杂志,2023,18(10):1160-1174. YE J Y,WANG Z,GONG Y T,et al. Neuroimaging standards for research into cerebral small vessel disease(STRIVE-2)—advances since 2013[J]. Chin J Stroke,2023,18(10):1160-1174. [5] KONTIS V,BENNETT J E,MATHERS C D,et al. Future life expectancy in 35 industrialised countries:projections with a Bayesian model ensemble[J]. Lancet,2017,389(10076):1323-1335. [6] TAY J,LISIECKA-FORD D M,HOLLOCKS M J,et al. Network neuroscience of apathy in cerebrovascular disease[J/OL]. Prog Neurobiol,2020,188:101785[2023-12-01]. https://doi.org/10.1016/j.pneurobio.2020.101785. [7] MORETTI R,CAVRESSI M,TOMIETTO P. Gait and apathy as relevant symptoms of subcortical vascular dementia[J]. Am J Alzheimers Dis Other Demen,2015,30(4):390-399. [8] HOLLOCKS M J,LAWRENCE A J,BROOKES R L,et al. Differential relationships between apathy and depression with white matter microstructural changes and functional outcomes[J]. Brain,2015,138(Pt 12):3803-3815. [9] 夏振西,黄敏莹,赵弘轶,等. 脑小血管病患者淡漠综合征的临床评定[J]. 中国卒中杂志,2020,15(4):354-359. XIA Z X,HUANG M Y,ZHAO H Y,et al. Clinical evaluation of apathy in patients with cerebral small vessel disease[J]. Chin J Stroke,2020,15(4):354-359. [10] 王晓静,陈晨,曹珊珊,等. 脑小血管病淡漠与功能脑网络及认知的相关性[J]. 中国神经精神疾病杂志,2021,47(6):341-347. WANG X J,CHEN C,CAO S S,et al. Correlation of apathy with functional brain networks and cognition in patients with cerebral small vessel disease[J]. Chin J Nerv Ment Dis,2021,47(6):341-347. [11] CLANCY U,GILMARTIN D,JOCHEMS A C C,et al. Neuropsychiatric symptoms associated with cerebral small vessel disease:a systematic review and meta-analysis[J]. Lancet Psychiatry,2021,8(3):225-236. [12] TAY J,TULADHAR A M,HOLLOCKS M J,et al. Apathy is associated with large-scale white matter network disruption in small vessel disease[J/OL]. Neurology,2019,92(11):e1157-e1167[2023-12-01]. https://doi.org/10.1212/WNL.0000000000007095. [13] LAVRETSKY H,ZHENG L,WEINER M W,et al. The MRI brain correlates of depressed mood,anhedonia,apathy,and anergia in older adults with and without cognitive impairment or dementia[J]. Int J Geriatr Psychiatry,2008,23(10):1040-1050. [14] KIM H J,KANG S J,KIM C,et al. The effects of small vessel disease and amyloid burden on neuropsychiatric symptoms:a study among patients with subcortical vascular cognitive impairments[J]. Neurobiol Aging,2013,34(7):1913-1920. [15] MIHALOV J,MIKULA P,BUDIŠ J,et al. Frontal cortical atrophy as a predictor of poststroke apathy[J]. J Geriatr Psychiatry Neurol,2016,29(4):171-176. [16] CARNES-VENDRELL A,DEUS J,MOLINA-SEGUIN J,et al. Depression and apathy after transient ischemic attack or minor stroke:prevalence,evolution and predictors[J/OL]. Sci Rep,2019,9(1):16248[2023-12-01]. https://doi.org/10.1038/s41598-019-52721-5. [17] DOUVEN E,STAALS J,FREEZE W M,et al. Imaging markers associated with the development of post-stroke depression and apathy:results of the cognition and affect after stroke—a prospective evaluation of risks study[J]. Eur Stroke J,2020,5(1):78-84. [18] COSIN C,SIBON I,POLI M,et al. Circadian sleep/wake rhythm abnormalities as a risk factor of a poststroke apathy[J]. Int J Stroke,2015,10(5):710-715. [19] LISIECKA-FORD D M,TOZER D J,MORRIS R G,et al. Involvement of the reward network is associated with apathy in cerebral small vessel disease[J/OL]. J Affect Disord,2018,232:116-121[2023-12-01]. https://doi.org/10.1016/j.jad.2018.02.006. [20] DEGUCHI K,KONO S,DEGUCHI S,et al. A novel useful tool of computerized touch panel-type screening test for evaluating cognitive function of chronic ischemic stroke patients[J/OL]. J Stroke Cerebrovasc Dis,2013,22(7):e197-206[2023-12-01]. https://doi.org/10.1016/j.jstrokecerebrovasdis.2012.11.011. [21] WHITE C L,MCCLURE L A,WALLACE P M,et al. The correlates and course of depression in patients with lacunar stroke:results from the secondary prevention of small subcortical strokes(SPS3)study[J]. Cerebrovasc Dis,2011,32(4):354-360. [22] NOBIS L,HUSAIN M. Apathy in Alzheimer’s disease[J/OL]. Curr Opin Behav Sci,2018,22:7-13[2023-12-01]. https://doi.org/10.1016/j.cobeha.2017.12.007. [23] MARSHALL G A,MONSERRATT L,HARWOOD D,et al. Positron emission tomography metabolic correlates of apathy in Alzheimer disease[J]. Arch Neurol,2007,64(7):1015-1020. [24] TEKIN S,CUMMINGS J L. Frontal-subcortical neuronal circuits and clinical neuropsychiatry:an update[J]. J Psychosom Res,2002,53(2):647-654. [25] DE SILVA T M,FARACI F M. Contributions of aging to cerebral small vessel disease[J]. Annu Rev Physiol,2020,82(1):275-295. [26] BULLMORE E,SPORNS O. Complex brain networks:graph theoretical analysis of structural and functional systems[J]. Nat Rev Neurosci,2009,10(3):186-198. [27] SNAPHAAN L,VAN DER WERF S,DE LEEUW F E. Time course and risk factors of post-stroke fatigue:a prospective cohort study[J]. Eur J Neurol,2011,18(4):611-617. [28] NAESS H,LUNDE L,BROGGER J,et al. Fatigue among stroke patients on long-term follow-up. The Bergen stroke study[J]. J Neurol Sci,2012,312(1/2):138-141. [29] CHEN Y K,QU J F,XIAO W M,et al. Poststroke fatigue:risk factors and its effect on functional status and health-related quality of life[J]. Int J Stroke,2015,10(4):506-512. [30] CHUNG C P,CHOU K H,CHEN W T,et al. Cerebral microbleeds are associated with physical frailty:a community-based study[J]. Neurobiol Aging,2016,44(1):143-150. [31] TANG W K,LIU X X,CHEN Y K,et al. Cerebral microbleeds and fatigue in stroke[J]. Eur Neurol,2014,71(5/6):213-216. [32] KLUGER B M,ZHAO Q,TANNER J J,et al. Structural brain correlates of fatigue in older adults with and without Parkinson’s disease[J/OL]. Neuroimage Clin,2019,22:101730[2023-12-01]. https://doi.org/10.1016/j.nicl.2019.101730. [33] PURI B K,COUNSELL S J,ZAMAN R,et al. Relative increase in choline in the occipital cortex in chronic fatigue syndrome[J]. Acta Psychiatr Scand,2002,106(3):224-226. [34] 陈媛媛,赵彦萍,方继良,等. 建立BOLD及MRS多模态fMRI针刺脑效应试验方案及其可行性研究[J]. 中国医学影像技术,2018,34(1):20-24. CHEN Y Y,ZHAO Y P,FANG J L,et al. Experiment design and feasibility of BOLD and MRS multimodal fMRI in analysis of brain effect induced by acupuncture[J]. Chin J Med Imaging Technol,2018,34(1):20-24. [35] BARNDEN L R,CROUCH B,KWIATEK R,et al. Evidence in chronic fatigue syndrome for severity-dependent upregulation of prefrontal myelination that is independent of anxiety and depression[J]. NMR Biomed,2015,28(3):404-413. [36] FLUGE Ø,TRONSTAD K J,MELLA O. Pathomechanisms and possible interventions in myalgic encephalomyelitis/chronic fatigue syndrome(ME/CFS)[J/OL]. J Clin Invest,2021,131(14):e150377[2023-12-01]. https://doi.org/10.1172/JCI150377. [37] STAHL-PEHE A,SELINSKI S,BÄCHLE C,et al. Screening for generalized anxiety disorder(GAD)and associated factors in adolescents and young adults with type 1 diabetes:cross-sectional results of a Germany-wide population-based study[J/OL]. Diabetes Res Clin Pract,2022,184:109197[2023-12-01]. https://doi.org/10.1016/j.diabres.2022.109197. [38] LI W,XIAO W M,CHEN Y K,et al. Anxiety in patients with acute ischemic stroke:risk factors and effects on functional status[J/OL]. Front Psychiatry,2019,10:257[2023-12-01]. https://doi.org/10.3389/fpsyt.2019.00257. [39] RAFFIELD L M,BRENES G A,COX A J,et al. Associations between anxiety and depression symptoms and cognitive testing and neuroimaging in type 2 diabetes[J]. J Diabetes Complications,2016,30(1):143-149. [40] KIM J T,PARK M S,YOON G J,et al. White matter hyperintensity as a factor associated with delayed mood disorders in patients with acute ischemic stroke[J]. Eur Neurol,2011,66(6):343-349. [41] JOHANSSON L,SKOOG I,GUSTAFSON D R,et al. Midlife psychological distress associated with late-life brain atrophy and white matter lesions:a 32-year population study of women[J]. Psychosom Med,2012,74(2):120-125. [42] LIND K,JONSSON M,KARLSSON I,et al. Depressive symptoms and white matter changes in patients with dementia[J]. Int J Geriatr Psychiatry,2006,21(2):119-125. [43] SIERRA C,DE LA SIERRA A,SALAMERO M,et al. Silent cerebral white matter lesions and cognitive function in middle-aged essential hypertensive patients[J]. Am J Hypertens,2004,17(6):529-534. [44] VOGELS R L,OOSTERMAN J M,VAN HARTEN B,et al. Neuroimaging and correlates of cognitive function among patients with heart failure[J]. Dement Geriatr Cogn Disord,2007,24(6):418-423. [45] CHEN Y J,DANG M X,ZHANG Z J. Brain mechanisms underlying neuropsychiatric symptoms in Alzheimer’s disease:a systematic review of symptom-general and-specific lesion patterns[J/OL]. Mol Neurodegener,2021,16(1):38[2023-12-01]. https://doi.org/10.1186/s13024-021-00456-1. [46] GRUPE D W,NITSCHKE J B. Uncertainty and anticipation in anxiety:an integrated neurobiological and psychological perspective[J]. Nat Rev Neurosci,2013,14(7):488-501. [47] DONKELAAR H J T. Clinical neuroanatomy:brain circuitry and its disorders[M]. Berlin:Springer Berlin Heidelberg,2011. [48] MAH L,BINNS M A,STEFFENS D C,et al. Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer disease[J]. Am J Geriatr Psychiatry,2015,23(5):466-476. [49] POULIN S P,DAUTOFF R,MORRIS J C,et al. Amygdala atrophy is prominent in early Alzheimer’s disease and relates to symptom severity[J]. Psychiatry Res,2011,194(1):7-13. [50] EHRENBERG A J,SUEMOTO C K,FRANÇA RESENDE E P,et al. Neuropathologic correlates of psychiatric symptoms in Alzheimer’s disease[J]. J Alzheimers Dis,2018,66(1):115-126. [51] MOHAMED NOUR A E A,JIAO Y,TENG G J,et al. Neuroanatomical associations of depression,anxiety and apathy neuropsychiatric symptoms in patients with Alzheimer’s disease[J]. Acta Neurol Belg,2021,121(6):1469-1480. [52] JIMENEZ J C,SU K,GOLDBERG A R,et al. Anxiety cells in a hippocampal-hypothalamic circuit[J/OL]. Neuron,2018,97(3):670-683,e6[2023-12-01]. https://doi.org/10.1016/j.neuron.2018.01.016. [53] JACINTO L R,CERQUEIRA J J,SOUSA N. Patterns of theta activity in limbic anxiety circuit preceding exploratory behavior in approach-avoidance conflict[J/OL]. Front Behav Neurosci,2016,10:171[2023-12-01]. https://doi.org/10.3389/fnbeh.2016.00171. [54] TAGAI K,NAGATA T,SHINAGAWA S,et al. Correlation between both morphologic and functional changes and anxiety in Alzheimer’s disease[J]. Dement Geriatr Cogn Disord,2014,38(3/4):153-160. [55] HASHIMOTO H,MONSERRATT L,NGUYEN P,et al. Anxiety and regional cortical glucose metabolism in patients with Alzheimer’s disease[J]. J Neuropsychiatry Clin Neurosci,2006,18(4):521-528. [56] YAO L,LI M Y,CAO J Z,et al. Study on acupuncture improving insomnia comorbid with depression and anxiety based on rs-fMRI:a protocol for systematic review and meta-analysis[J/OL]. Medicine(Baltimore),2021,100(20):e25988[2023-12-01]. https://doi.org/10.1097/MD.0000000000025988. [57] 王兴隆,朱弘子,蚁舒,等. 首发未服药焦虑障碍患者脑白质弥散张量成像的对照研究[J]. 国际精神病学杂志,2019,46(2):228-230. WANG X L,ZHU H Z,YI S,et al. A comparative study of the white matter by using diffusion tensor imaging in first-episode,medication-na(i)ve anxiety disorders[J]. Journal of International Psychiatry,2019,46(2):228-230. [58] 陆林. 沈渔邨精神病学[M]. 6版. 北京:人民卫生出版社,2018. LU L. Shen YuCun’s Psychiatry[M]. 6th ed. Beijing:People’s Medical Publishing House,2018. [59] PAVLOVIC A M,PEKMEZOVIC T,ZIDVERC TRAJKOVIC J,et al. Baseline characteristic of patients presenting with lacunar stroke and cerebral small vessel disease may predict future development of depression[J]. Int J Geriatr Psychiatry,2016,31(1):58-65. [60] RENSMA S P,VAN SLOTEN T T,LAUNER L J,et al. Cerebral small vessel disease and risk of incident stroke,dementia and depression,and all-cause mortality:a systematic review and meta-analysis[J/OL]. Neurosci Biobehav Rev,2018,90:164-173[2023-12-01]. https://doi.org/10.1016/j.neubiorev.2018.04.003. [61] FANG Y Y,QIN T T,LIU W H,et al. Cerebral small-vessel disease and risk of incidence of depression:a meta-analysis of longitudinal cohort studies[J/OL]. J Am Heart Assoc,2020,9(15):e016512[2023-12-01]. https://doi.org/10.1161/JAHA. 120.016512. [62] TEODORCZUK A,O’BRIEN J T,FIRBANK M J,et al. White matter changes and late-life depressive symptoms:longitudinal study[J/OL]. Br J Psychiatry,2007,191:212-217[2023-12-01]. https://doi.org/10.1192/bjp.bp.107.036756. [63] MAKIN S D,TURPIN S,DENNIS M S,et al. Cognitive impairment after lacunar stroke:systematic review and meta-analysis of incidence,prevalence and comparison with other stroke subtypes[J]. J Neurol Neurosurg Psychiatry,2013,84(8):893-900. [64] ZHANG X,TANG Y,XIE Y,et al. Total magnetic resonance imaging burden of cerebral small-vessel disease is associated with post-stroke depression in patients with acute lacunar stroke[J]. Eur J Neurol,2017,24(2):374-380. [65] DIREK N,PEREZ H S,AKOUDAD S,et al. Markers of cerebral small vessel disease and severity of depression in the general population[J/OL]. Psychiatry Res Neuroimaging,2016,253:1-6[2023-12-01]. https://doi.org/10.1016/j.pscychresns.2016.05.002. [66] DOTSON V M,ZONDERMAN A B,KRAUT M A,et al. Temporal relationships between depressive symptoms and white matter hyperintensities in older men and women[J]. Int J Geriatr Psychiatry,2013,28(1):66-74. [67] VERSLUIS C E,VAN DER MAST R C,VAN BUCHEM M A,et al. Progression of cerebral white matter lesions is not associated with development of depressive symptoms in elderly subjects at risk of cardiovascular disease:the PROSPER study[J]. Int J Geriatr Psychiatry,2006,21(4):375-381. [68] LEVADA O A,TROYAN A S. Poststroke depression biomarkers:a narrative review[J/OL]. Front Neurol,2018,9:577[2023-12-01]. https://doi.org/10.3389/fneur.2018.00577. [69] HU J,ZHOU W,ZHOU Z M,et al. miR-22 and cerebral microbleeds in brainstem and deep area are associated with depression one month after ischemic stroke[J/OL]. Braz J Med Biol Res,2020,53(5):e9162[2023-12-01]. https://doi.org/10.1590/1414-431x20209162. [70] NUNES P V,SUEMOTO C K,LEITE R E P,et al. Factors associated with brain volume in major depression in older adults without dementia:results from a large autopsy study[J]. Int J Geriatr Psychiatry,2018,33(1):14-20. [71] ZHUO C J,ZHU J J,WANG C L,et al. Different spatial patterns of brain atrophy and global functional connectivity impairments in major depressive disorder[J]. Brain Imaging Behav,2017,11(6):1678-1689. [72] MULLINS N,HODGSON K,TANSEY K E,et al. Investigation of blood mRNA biomarkers for suicidality in an independent sample[J/OL]. Transl Psychiatry,2014,4(10):e474[2023-12-01]. https://doi.org/10.1038/tp.2014.112. [73] OUDEGA M L,SIDDIQUI A,WATTJES M P,et al. Are apathy and depressive symptoms related to vascular white matter hyperintensities in severe late life depression?[J]. J Geriatr Psychiatry Neurol,2021,34(1):21-28. [74] LIN C,HUANG C M,KARIM H T,et al. Greater white matter hyperintensities and the association with executive function in suicide attempters with late-life depression[J/OL]. Neurobiol Aging,2021,103:60-67[2023-12-01]. https://doi.org/10.1016/j. neurobiolaging.2020.12.016. [75] BROOKES R L,HERBERT V,LAWRENCE A J,et al. Depression in small-vessel disease relates to white matter ultrastructural damage,not disability[J]. Neurology,2014,83(16):1417-1423. [76] BIJANKI K R,MATSUI J T,MAYBERG H S,et al. Depressive symptoms related to low fractional anisotropy of white matter underlying the right ventral anterior cingulate in older adults with atherosclerotic vascular disease[J/OL]. Front Hum Neurosci,2015,9:408[2023-12-01]. https://doi.org/10.3389/fnhum.2015.00408. [77] MACLULLICH A M,FERGUSON K J,MILLER T,et al. Unravelling the pathophysiology of delirium:a focus on the role of aberrant stress responses[J]. J Psychosom Res,2008,65(3):229-238. [78] TANG W K,CHEN Y K,LU J Y,et al. Microbleeds and post-stroke emotional lability[J]. J Neurol Neurosurg Psychiatry,2009,80(10):1082-1086. |
[1] | WANG Yilong. Diagnosis and Treatment of Cerebral Small Vessel Disease and the Way of Future Exploration [J]. Chinese Journal of Stroke, 2024, 19(4): 363-374. |
[2] | YANG Yingying, WANG Yilong. Bibliometric Analysis of Researches on Perivascular Spaces from 2013 to 2023 [J]. Chinese Journal of Stroke, 2024, 19(4): 414-422. |
[3] | PAN Xijuan, XING Yingqi, LIU Yumei. Application Progress of Vascular Ultrasound in Cerebral Small Vessel Disease [J]. Chinese Journal of Stroke, 2024, 19(3): 343-348. |
[4] | DAI Jie, ZHANG Suxiang, ZHAO Shasha, ZHANG Xiaofeng. Analysis of Influencing Factors of Cognitive Impairment in Patients with Cerebral Small Vessel Disease and Construction and Validation of a Nomogram Model [J]. Chinese Journal of Stroke, 2024, 19(10): 1136-1142. |
[5] | ZU Yu, YU Shasha, ZHANG Yujing, LYU Jing, FENG Xuedan. Heterozygous HTRA1-related Hereditary Cerebral Small Vessel Disease: A Case Report and Literature Review [J]. Chinese Journal of Stroke, 2023, 18(9): 1054-1059. |
[6] | ZHU Xiaoyuan, HAO Guisheng. Research Progress on the Relationship between Cerebral Small Vessel Disease and Dizziness Symptoms [J]. Chinese Journal of Stroke, 2023, 18(8): 940-946. |
[7] | CHEN Yuan, ZHOU Yuying, LI Pan. Hereditary Cerebral Small Vessel Disease with Abnormal Mental Behavior: A Case Report [J]. Chinese Journal of Stroke, 2023, 18(11): 1248-1254. |
[8] | YE Jinyi, WANG Zan, GONG Yutian, GUO Lei, GUO Tong, HU Kun, LU Yao, SHAN Shuyi, WANG Ling, YUE Fangfang, ZHU Jinghan, ZHENG Xinya, CHEN Weiqi, WANG Yilong. Neuroimaging Standards for Research into Cerebral Small Vessel Disease (STRIVE-2) —Advances Since 2013 [J]. Chinese Journal of Stroke, 2023, 18(10): 1160-1174. |
[9] | YE Jinyi, CHEN Weiqi, WANG Yilong. Interpretation of the Updates on Standards for Reporting Vascular Changes on Neuroimaging 2 [J]. Chinese Journal of Stroke, 2023, 18(10): 1175-1180. |
[10] |
ZENG Huixing, LI Jinbiao, WANG Meng, OUYANG Fubing, YU Lei, YI Ming, GUO Jiayu, NI Ruichen, CUI Liqian, FAN Yuhua.
Spatial Statistical Analysis based on Fiber Tracerto Study the Changes of Brain Microstructure in Patients with Cerebral Small Vessel Disease Combined with Obstructive Sleep Apnea
[J]. Chinese Journal of Stroke, 2023, 18(05): 503-513.
|
[11] |
LIU Yang, WANG Rui, ZHANG Xiang, SUN Huiling, MA Yinghu.
Risk factors of Cerebral Microbleeds in Patients with Symptomatic and Atherosclerotic Cerebral Small Vessel Disease
[J]. Chinese Journal of Stroke, 2023, 18(04): 440-449.
|
[12] |
CHEN Yuewei, XU Qun.
The Progress of Peripheral Biomarkers and Multi-omics of Cerebral Small Vessel Disease
[J]. Chinese Journal of Stroke, 2023, 18(03): 340-346.
|
[13] | TIAN Yu, GUAN Ling, WANG Yilong. Correlation of Urinary Dysfunction and Autonomic Nervous Function in Patients with Cerebral Small Vessel Disease [J]. Chinese Journal of Stroke, 2023, 18(01): 76-82. |
[14] | ZHENG Zhanjun, ZHAO Xingquan. Advances in Correlation of Imaging Markers of Cerebral Small Vessel Disease with Spontaneous Hypertensive Intracerebral Hemorrhage [J]. Chinese Journal of Stroke, 2022, 17(12): 1396-1402. |
[15] | CHEN Chao, WAN Huijuan, DONG Wenyu, WANG Shengsong, YU Ping, SHAO Xiaoqiu. The Association between Total Cerebral Small Vessel Disease Burden and Cognitive Function in Middle-aged and Elderly Patients With Epilepsy [J]. Chinese Journal of Stroke, 2022, 17(06): 622-627. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||